Revance Therapeutics Inc (NASDAQ:RVNC)

25.57
Delayed Data
As of May 27
 +0.10 / +0.39%
Today’s Change
14.02
Today|||52-Week Range
34.20
+50.94%
Year-to-Date

Today’s Trading

Previous close25.47
Today’s open25.64
Day’s range-- - --
Volume221,462
Average volume (3 months)180,057
Market cap$612.3M
Dividend yield--
Data as of 05/27/2015

Growth & Valuation

Earnings growth (last year)-408.57%
Earnings growth (this year)-4.01%
Earnings growth (next 5 years)--
Revenue growth (last year)-37.93%
P/E ratioNM
Price/Sales857.68
Price/Book3.45

Competitors

 Today’s
change
Today’s
% change
--China Health Group I...0.000.00%
NWBONorthwest Biotherape...+0.42+5.35%
OREXOrexigen Therapeutic...-0.02-0.30%
CORTCorcept Therapeutics...+0.03+0.52%
Data as of 05/28/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)-$0.84
Annual revenue (last year)$383.0K
Annual profit (last year)-$62.9M
Net profit margin-16,427.42%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
L. Daniel Browne
CFO &
Executive VP-Corporate Development
Lauren P. Silvernail
Corporate headquarters
Newark, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers